Pixantrone Combination Therapy for First-line Treatment of,Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe,Toxicities Including Heart Damage When Compared to,Doxorubicin-based Therapy ( al Information Contact: T: 800.715...)

(Date:11/23/2009)...ICAGO,Nov.23/PRNewswire/--TwooftheChicagoarea,slea...cinganewerainwomen,sbreastimaging,couplingthelates...nosticultrasoundwiththeabilitytohavethefullrangeof...hepatientbeforesheleavestheoffice.Drs.AhmedFaragan...ch,withoutthecurrent6-9monthwaitforanappointmentco...

(Date:11/23/2009)...ONVILLE,Pa.,Nov.23/PRNewswire-FirstCall/--WestPhar...hatthecompany,sChiefOperatingOfficerMatthewT.Mulla...identandformerChiefOperatingOfficerStevenA.Ellers,...ordertoprovidemanagerialcontinuityandsupportfollow..., Westisaglobalmanufacturerofcomponentsandsystemsf...

(Date:11/23/2009)...MBRIDGE,Mass.,Nov.23/PRNewswire/--LigonDiscovery,I...hnologytofinddrugsagainsthigh-valuetargets,todayan...anErrolB.DeSouzaasLigon,sExecutiveChairmanoftheBoa...ecutiveChairmanoftheBoard,"saidPatrickKleyn,Ligon,...,sbreadthofexperienceinthelifesciencesindustry--pa...

Breaking Medicine Technology:Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman 2 Uncertainty Surrounds Testing for Alzheimers 58797 1 Uncertainty Surrounds Testing for Alzheimers 58797 2 Uncertainty Surrounds Testing for Alzheimers 58797 3 Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 1 Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 2 Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 3 Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 4 Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 5 Advances in Treating Hip Pain To Be Focus of Hip Arthroscopy Meeting 5200 1 Advances in Treating Hip Pain To Be Focus of Hip Arthroscopy Meeting 5200 2 Advances in Treating Hip Pain To Be Focus of Hip Arthroscopy Meeting 5200 3

[0] Noted Diagnostic Radiologists Joan Werber, D.O., Ahmed Farag, M.D., C.M., Join Forces to Create Diagnostic Imaging Specialists of Chicago [0] West Announces Management Change [0] Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman

...ent shows no additional very late stent thrombosis...ton Scientific Corporation (NYSE: BSX ) today ann...II clinical trial, demonstrating continued,long-te...-eluting stent,system. Among the findings, the TAX...ween years four and five, while the bare-metal con...

...tralia, Aug. 31 What and When Data from a six-m...r,format at worldsleep07: The 5th World Congress o... Medicine Societies to be held in Cairns, Australi...emonstrated that ramelteon,was effective in reduci...,placebo in adult patients with chronic insomnia. ...

Other Medicine Technology:Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 2 Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 3 Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 4 New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia 2 New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia 3

Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia

(Date:11/24/2009)... Mercy Health System will be offering a free onli...bert Epstein, MD, board certified ophthalmologist ...ww.MercyWebinars.com , (...ll present a live webinar on LASIK Vision Correcti... or home computer and is free to anyone attending....

(Date:11/24/2009)...4/PRNewswire/--MinuteClinic,thepioneerandlargestpr...sopeneditsfirstretailhealthcarecenterinWashington,...linicisopensevendaysaweekandwillservepatientsinNor...on,KingmanPark,AtlasDistrict,IvyCityandtheGallaude...ocatedstore-basedclinic,weareexpandingaccesstohigh...

(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--RegeneronPharmaceutic...tthe21stAnnualPiperJaffrayHealthcareConferenceonTu...4:00p.m.EasternTime.Thesessionmaybeaccessedthrough...torRelationspage.Anarchivedversionofthepresentatio...31,2009.AdditionalinformationaboutRegeneronandrece...

(Date:11/24/2009)...is behind reasoning that testing less is OK , ...orld of cancer screening has been upended in the p...ve Services Task Force (USPSTF) just raise the age...ogram from 40 to 50, but the American College of O...olescents should be spared the inconvenience and p...

(Date:11/24/2009)... Along with his state-of-the-art website, Dr. Ric...o interact with patients and share information abo...nd the procedures that he offers. , ... -- North Carolina plastic surgeon Dr. Richard C...ite Facebook to expand his reach and keep an ongoi...

Breaking Medicine News(10 mins):Health News:Free LASIK Surgery Webinar 2 Health News:Free LASIK Surgery Webinar 3 Health News:Free LASIK Surgery Webinar 4 Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 2 Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 3 Health News:Recent Cancer Screening Changes Leave Many Confused 2 Health News:Recent Cancer Screening Changes Leave Many Confused 3 Health News:Recent Cancer Screening Changes Leave Many Confused 4 Health News:North Carolina Plastic Surgeon Embracing Social Media to Connect with Patients and Reach Out to Community 2 Health News:North Carolina Plastic Surgeon Embracing Social Media to Connect with Patients and Reach Out to Community 3

[0] Free LASIK Surgery Webinar [0] MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast [0] Regeneron Announces Presentation at the 21st Annual Piper Jaffray Healthcare Conference [0] Recent Cancer Screening Changes Leave Many Confused [0] North Carolina Plastic Surgeon Embracing Social Media to Connect with Patients and Reach Out to Community

...c., launches,a new informational web site, TNSReco...roduct, TNS Recovery Complex(R). The site is desig... a greater understanding of the,science and effica...es -- where visitors can learn,more about the ingr...

...th resistance to imatinib (Gleevec) in patients wi... report in the June 24 online issue of the Journa...s the standard therapy for newly diagnosed CML pat...gene. In other cases, though, researchers find no ...

...uticals, Inc. (Nasdaq: MAPP ) today announced tha...chnologies Limited ("Eiffel"), has,agreed to trans...icensed,intellectual property and know-how, as wel... the successful,transfer of the intellectual prope...

...t,and CEO of America,s Health Insurance Plans (AHI...se to the U.S. House of Representatives,passage of...lation that would require Medicare,Advantage benef...e details of this hastily passed legislation, they...

...ion drive making inroads, CDC says , , T...ion Americans had diabetes in 2007, an increase of...ers for Disease Control and Prevention reported Tu...r two years, the proportion of people with diabete...

...tant Professor Adela Ben-Yakar at The University o...pel" that destroys a single cell while leaving nea...n of surgeries for cancer, epilepsy and other dise...same precision, what you are doing to guide your m...

Other Medicine News:Health News:SkinMedica(R) Launches New Informational Web Site 2 Health News:SkinMedica(R) Launches New Informational Web Site 3 Health News:Activation of LYN kinase is associated with imatinib-resistance in CML patients 2 Health News:MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited 2 Health News:MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited 3 Health News:AHIP Statement on House Passage of H.R. 6331 2 Health News:24 Million Americans Had Diabetes in 2007 2 Health News:Laser surgery probe targets individual cancer cells 2

SkinMedica(R) Launches New Informational Web Site Activation of LYN kinase is associated with imatinib-resistance in CML patients MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited AHIP Statement on House Passage of H.R. 6331 24 Million Americans Had Diabetes in 2007 Laser surgery probe targets individual cancer cells

Sphincter of Oddi Manometry Application

...comprise the SmartPill GI Monitoring System., ,Th...Monitoring System: SmartPill pH.p Capsule software...otiliGI software. These three components are integ...Monitoring System and function together with syste...

...GRAM NET™ (PNET) works with the Polygraf&tra...yze pressure signals from continuous pull-through ...phincter (LES)., ,Continuous pull-through procedu...heter Puller, but they may be carried out manually...

... for POLYGRAM NET™ works with the Polygraf&t...alyze multichannel EGG signals. The EGG analysis t...orming an automatic electrode impedance check on e... recording. If the electrode impedance is measured...

Medicine Products:

Sphincter of Oddi Manometry Application SmartPill pH.p Capsule software Vector Volume Application Electrogastrography (EGG) Analysis

( al Information Contact: T: 800.715...)Pixantrone Combination Therapy for First-line Treatment of,Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe,Toxicities Including Heart Damage When Compared to,Doxorubicin-based Therapy,Health